Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC

**Athena Diagnostics v. Mayo Collaborative Services: Patent Dispute Over Medical Testing** This case was about a patent dispute between two medical companies. Athena Diagnostics owned a patent for a method of identifying certain genetic mutations related to neurological disorders. Mayo Collaborative Services challenged this patent, arguing it was invalid because it covered basic scientific concepts that shouldn't be patentable. The Federal Circuit Court of Appeals ruled in favor of Mayo. The court decided that Athena's patent was invalid because it only covered an "abstract idea" - essentially the concept of identifying genetic mutations - without adding anything significantly new or inventive beyond that basic scientific principle. The court determined that you cannot patent fundamental scientific concepts or natural phenomena, even when applied to medical testing. This ruling matters for workers because it affects innovation and competition in the healthcare industry. When overly broad patents are struck down, it can lead to more competition among companies developing medical tests and treatments. This competition can potentially result in lower costs for medical services and faster development of new diagnostic tools, which could benefit workers who rely on employer-provided health insurance or need medical testing services.